| Year |
Citation |
Score |
| 2019 |
May S, Brown SP, Schmicker RH, Emerson SS, Nkwopara E, Ginsburg AS. Non-inferiority designs comparing placebo to a proven therapy for childhood pneumonia in low-resource settings. Clinical Trials (London, England). 1740774519888460. PMID 31814441 DOI: 10.1177/1740774519888460 |
0.347 |
|
| 2016 |
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Frandsen KB, Rabøl R, Buse JB. Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1. American Heart Journal. 179: 175-83. PMID 27595693 DOI: 10.1016/J.Ahj.2016.06.004 |
0.353 |
|
| 2016 |
Shoben AB, Rudser KD, Emerson SS. More data, less information? Potential for nonmonotonic information growth using GEE. Journal of Biopharmaceutical Statistics. PMID 27049897 DOI: 10.1080/10543406.2016.1167071 |
0.672 |
|
| 2014 |
Shoben AB, Emerson SS. Violations of the independent increment assumption when using generalized estimating equation in longitudinal group sequential trials. Statistics in Medicine. 33: 5041-56. PMID 25224560 DOI: 10.1002/Sim.6306 |
0.67 |
|
| 2014 |
Levin GP, Emerson SC, Emerson SS. An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size. Biometrics. 70: 556-67. PMID 24766094 DOI: 10.1111/Biom.12168 |
0.757 |
|
| 2013 |
Levin GP, Emerson SC, Emerson SS. Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation. Statistics in Medicine. 32: 1259-75; discussion . PMID 23081665 DOI: 10.1002/Sim.5662 |
0.749 |
|
| 2013 |
Devlin SM, Thomas EG, Emerson SS. Robustness of approaches to ROC curve modeling under misspecification of the underlying probability model Communications in Statistics - Theory and Methods. 42: 3655-3664. DOI: 10.1080/03610926.2011.636166 |
0.454 |
|
| 2013 |
Levin GP, Emerson SC, Emerson SS. Authors' response to 'Adaptive clinical trial designs with pre-specified rules formodifying the sample size: Adifferentperspective' Statistics in Medicine. 32: 1280-1282. DOI: 10.1002/Sim.5749 |
0.751 |
|
| 2012 |
Little RJ, D'Agostino R, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Frangakis C, Hogan JW, Molenberghs G, Murphy SA, Neaton JD, Rotnitzky A, Scharfstein D, Shih WJ, Siegel JP, et al. The prevention and treatment of missing data in clinical trials. The New England Journal of Medicine. 367: 1355-60. PMID 23034025 DOI: 10.1056/Nejmsr1203730 |
0.403 |
|
| 2012 |
Little RJ, Cohen ML, Dickersin K, Emerson SS, Farrar JT, Neaton JD, Shih W, Siegel JP, Stern H. The design and conduct of clinical trials to limit missing data. Statistics in Medicine. 31: 3433-43. PMID 22829439 DOI: 10.1002/Sim.5519 |
0.439 |
|
| 2012 |
Rudser KD, LeBlanc ML, Emerson SS. Distribution-free inference on contrasts of arbitrary summary measures of survival. Statistics in Medicine. 31: 1722-37. PMID 22362470 DOI: 10.1002/Sim.4505 |
0.549 |
|
| 2011 |
Emerson SS, Levin GP, Emerson SC. Comments on 'Adaptive increase in sample size when interim results are promising: a practical guide with examples'. Statistics in Medicine. 30: 3285-301; discussion. PMID 22105691 DOI: 10.1002/Sim.4271 |
0.759 |
|
| 2011 |
Emerson SC, Rudser KD, Emerson SS. Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings. Statistics in Medicine. 30: 1199-217. PMID 21538450 DOI: 10.1002/Sim.4156 |
0.633 |
|
| 2011 |
Hostler D, Everson-Stewart S, Rea TD, Stiell IG, Callaway CW, Kudenchuk PJ, Sears GK, Emerson SS, Nichol G. Effect of real-time feedback during cardiopulmonary resuscitation outside hospital: prospective, cluster-randomised trial. Bmj (Clinical Research Ed.). 342: d512. PMID 21296838 DOI: 10.1136/Bmj.D512 |
0.726 |
|
| 2011 |
Bulger EM, May S, Kerby JD, Emerson S, Stiell IG, Schreiber MA, Brasel KJ, Tisherman SA, Coimbra R, Rizoli S, Minei JP, Hata JS, Sopko G, Evans DC, Hoyt DB, et al. Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial. Annals of Surgery. 253: 431-41. PMID 21178763 DOI: 10.1097/Sla.0B013E3181Fcdb22 |
0.308 |
|
| 2010 |
Emerson SS, Fleming TR. Adaptive methods: telling "the rest of the story". Journal of Biopharmaceutical Statistics. 20: 1150-65. PMID 21058111 DOI: 10.1080/10543406.2010.514457 |
0.465 |
|
| 2010 |
Everson-Stewart S, Emerson SS. Bio-creep in non-inferiority clinical trials. Statistics in Medicine. 29: 2769-80. PMID 20809482 DOI: 10.1002/Sim.4053 |
0.746 |
|
| 2010 |
Nichol G, Powell JL, Emerson S. On coenrollment in clinical resuscitation studies: review and experience from randomized trials. Resuscitation. 81: 792-5. PMID 20418007 DOI: 10.1016/J.Resuscitation.2010.03.014 |
0.408 |
|
| 2010 |
Newgard CD, Rudser K, Hedges JR, Kerby JD, Stiell IG, Davis DP, Morrison LJ, Bulger E, Terndrup T, Minei JP, Bardarson B, Emerson S. A critical assessment of the out-of-hospital trauma triage guidelines for physiologic abnormality. The Journal of Trauma. 68: 452-62. PMID 20154558 DOI: 10.1097/Ta.0B013E3181Ae20C9 |
0.494 |
|
| 2010 |
Rudser K, Shoben A, Emerson S. 122. Statistical issues in clinical trials: Information growth in longitudinal trials Molecular Genetics and Metabolism. 99: S33. DOI: 10.1016/J.Ymgme.2009.10.139 |
0.712 |
|
| 2009 |
Newgard CD, Rudser K, Atkins DL, Berg R, Osmond MH, Bulger EM, Davis DP, Schreiber MA, Warden C, Rea TD, Emerson S. The availability and use of out-of-hospital physiologic information to identify high-risk injured children in a multisite, population-based cohort Prehospital Emergency Care. 13: 420-431. PMID 19731152 DOI: 10.1080/10903120903144882 |
0.497 |
|
| 2008 |
Tang L, Emerson SS, Zhou XH. Nonparametric and semiparametric group sequential methods for comparing accuracy of diagnostic tests. Biometrics. 64: 1137-45. PMID 18371124 DOI: 10.1111/J.1541-0420.2008.01000.X |
0.364 |
|
| 2008 |
Rudser KD, Emerson SS. Implementing type I & type II error spending for two-sided group sequential designs. Contemporary Clinical Trials. 29: 351-8. PMID 17933592 DOI: 10.1016/J.Cct.2007.09.002 |
0.574 |
|
| 2007 |
Emerson SS, Kittelson JM, Gillen DL. Frequentist evaluation of group sequential clinical trial designs. Statistics in Medicine. 26: 5047-80. PMID 17573678 DOI: 10.1002/Sim.2901 |
0.638 |
|
| 2007 |
Emerson SS, Kittelson JM, Gillen DL. Bayesian evaluation of group sequential clinical trial designs. Statistics in Medicine. 26: 1431-49. PMID 17066402 DOI: 10.1002/Sim.2640 |
0.639 |
|
| 2007 |
Gillen DL, Emerson SS. Nontransitivity in a class of weighted logrank statistics under nonproportional hazards Statistics and Probability Letters. 77: 123-130. DOI: 10.1016/J.Spl.2006.06.001 |
0.58 |
|
| 2006 |
Emerson SS. Issues in the use of adaptive clinical trial designs. Statistics in Medicine. 25: 3270-96; discussion . PMID 16906553 DOI: 10.1002/Sim.2626 |
0.44 |
|
| 2005 |
Combes B, Emerson SS, Flye NL, Munoz SJ, Luketic VA, Mayo MJ, McCashland TM, Zetterman RK, Peters MG, Di Bisceglie AM, Benner KG, Kowdley KV, Carithers RL, Rosoff L, Garcia-Tsao G, et al. Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis. Hepatology (Baltimore, Md.). 42: 1184-93. PMID 16250039 DOI: 10.1002/Hep.20897 |
0.313 |
|
| 2005 |
Gillen DL, Emerson SS. A note on P-values under group sequential testing and nonproportional hazards. Biometrics. 61: 546-51. PMID 16011703 DOI: 10.1111/J.1541-0420.2005.040342.X |
0.579 |
|
| 2005 |
Kittelson JM, Sharples K, Emerson SS. Group sequential clinical trials for longitudinal data with analyses using summary statistics. Statistics in Medicine. 24: 2457-75. PMID 15977295 DOI: 10.1002/Sim.2127 |
0.476 |
|
| 2005 |
Gillen DL, Emerson SS. Information Growth in a Family of Weighted Logrank Statistics Under Repeated Analyses Sequential Analysis. 24: 1-22. DOI: 10.1081/Sqa-200046825 |
0.611 |
|
| 2003 |
Burington BE, Emerson SS. Flexible implementations of group sequential stopping rules using constrained boundaries. Biometrics. 59: 770-7. PMID 14969454 DOI: 10.1111/J.0006-341X.2003.00090.X |
0.402 |
|
| 2002 |
Ball AM, Gillen DL, Sherrard D, Weiss NS, Emerson SS, Seliger SL, Kestenbaum BR, Stehman-Breen C. Risk of hip fracture among dialysis and renal transplant recipients. Jama. 288: 3014-8. PMID 12479766 DOI: 10.1001/Jama.288.23.3014 |
0.487 |
|
| 2002 |
Lumley T, Diehr P, Emerson S, Chen L. The importance of the normality assumption in large public health data sets. Annual Review of Public Health. 23: 151-69. PMID 11910059 DOI: 10.1146/Annurev.Publhealth.23.100901.140546 |
0.307 |
|
| 2001 |
Emerson JF, Emerson SS. The impact of requisition design on laboratory utilization American Journal of Clinical Pathology. 116: 879-884. PMID 11764077 DOI: 10.1309/Wc83-Erly-Nedf-471E |
0.312 |
|
| 2001 |
Miller ME, Morgan TM, Espeland MA, Emerson SS. Group comparisons involving missing data in clinical trials: A comparison of estimates and power (size) for some simple approaches Statistics in Medicine. 20: 2383-2397. PMID 11512129 DOI: 10.1002/Sim.904 |
0.388 |
|
| 1999 |
Kittelson JM, Emerson SS. A unifying family of group sequential test designs Biometrics. 55: 874-882. PMID 11315020 DOI: 10.1111/J.0006-341X.1999.00874.X |
0.366 |
|
| 1997 |
Carithers R.L. J, Emerson SS. Therapy of hepatitis C: Meta-analysis of interferon alfa-2b trials Hepatology. 26. PMID 9305670 DOI: 10.1002/Hep.510260715 |
0.325 |
|
| 1997 |
Emerson SS, Kittelson JM. A computationally simpler algorithm for the UMVUE of a normal mean following a group sequential trial Biometrics. 53: 365-369. PMID 9147601 DOI: 10.2307/2533122 |
0.33 |
|
| 1997 |
Emerson SS, Kittelson JM. 13 A unified family of group sequential designs Controlled Clinical Trials. 18: S49. DOI: 10.1016/S0197-2456(97)90998-3 |
0.426 |
|
| 1995 |
Emerson SS. Stopping a clinical trial very early based on unplanned interim analyses: A group sequential approach Biometrics. 51: 1152-1162. PMID 7548699 DOI: 10.2307/2533015 |
0.337 |
|
| 1990 |
Emerson SS, Fleming TR. Interim analyses in clinical trials Oncology (Williston Park, N.Y.). 4: 126-133; discussion . PMID 2144441 |
0.317 |
|
| 1990 |
Emerson SS, Fleming TR. Parameter estimation following group sequential hypothesis testing Biometrika. 77: 875-892. DOI: 10.1093/Biomet/77.4.875 |
0.364 |
|
| 1989 |
Emerson SS, Fleming TR. Symmetric group sequential test designs Biometrics. 45: 905-923. PMID 2675998 DOI: 10.2307/2531692 |
0.383 |
|
| 1987 |
Green SJ, Fleming TR, Emerson S. Effects on overviews of early stopping rules for clinical trials Statistics in Medicine. 6: 361-367. PMID 3616289 DOI: 10.1002/Sim.4780060329 |
0.444 |
|
| Show low-probability matches. |